INVO Bioscience, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the annual meeting of stockholders held by INVO Bioscience, Inc. on October 12, 2022. The company is incorporated in Nevada and its common stock trades on The Nasdaq Stock Market LLC under the symbol "INVO".
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial statements. Consequently, data regarding revenue, profit, cash flow, margins, debt, and liquidity is not provided in this document.
Material Changes and Voting Results
The filing details the outcomes of three proposals voted upon by stockholders. A total of 12,169,714 shares were entitled to vote, with 9,074,727 shares present, constituting a quorum.
- Proposal 1: Election of Directors - Stockholders elected six directors: Steven Shum, Trent Davis, Barbara Ryan, Jeffrey Segal, Matthew Szot, and Rebecca Messina. Notably, there were 5,147,494 broker non-votes for each nominee.
- Proposal 2: Ratification of Auditors - Stockholders ratified the selection of M&K CPAS, PLLC as the independent registered public accounting firm for the fiscal year ending December 31, 2022. The vote was 8,888,232 For, 182,404 Against, and 4,091 Abstain.
- Proposal 3: Stock Incentive Plan - Stockholders approved the Second Amended and Restated 2019 Stock Incentive Plan. The vote was 3,247,429 For, 663,733 Against, and 16,071 Abstain, with 5,147,494 broker non-votes.
Guidance, Outlook, and Risks
The filing does not provide management commentary, financial guidance, outlook, or specific risk factors beyond the standard disclosure of the voting results.
Key Facts for Investor Verification
- Verify the impact of the approved Second Amended and Restated 2019 Stock Incentive Plan on potential future equity dilution.
- Review the significant number of broker non-votes (5,147,494) on the director elections and the stock incentive plan, indicating shares held by brokers that were not voted on these specific matters.
- Confirm the tenure of the newly elected board members, who serve until the next annual meeting of stockholders.
- Check subsequent filings (e.g., 10-K or 10-Q) for the financial performance of the company, as this 8-K contains no financial data.